Literature DB >> 2835420

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Y Yamaguchi1, Y Hayashi, Y Sugama, Y Miura, T Kasahara, S Kitamura, M Torisu, S Mita, A Tominaga, K Takatsu.   

Abstract

The recent molecular cloning of the complementary DNA encoding T cell--replacing factor (TRF) has demonstrated that a single molecule is responsible for B cell growth factor II (BCGF-II) activity and eosinophil differentiation activity. It has been proposed that this molecule be called interleukin 5 (IL-5). We previously reported that purified rIL-5 supports the terminal differentiation and proliferation of eosinophilic precursors. In this study, we examined the effects of IL-5 on functional activities of mature eosinophils. IL-5 maintained the viability of mature eosinophils obtained from peritoneal exudate cells of mice infected with parasites. It also induced superoxide anion production in a dose-dependent manner. The Boyden's chamber Millipore assay revealed that IL-5 had a marked chemokinetic effect on eosinophils in a dose-dependent manner. Moreover, IL-5 was found to be an eosinophil chemotactic factor by the checkerboard assay. In conclusion, IL-5 is suggested to play an important role in increasing the functional activities of eosinophils as well as their production in allergic and parasitic diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835420      PMCID: PMC2188945          DOI: 10.1084/jem.167.5.1737

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.

Authors:  A R Anwar; A B Kay
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

2.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4.

Authors:  C J Sanderson; A O'Garra; D J Warren; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin.

Authors:  D G Colley
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

4.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells.

Authors:  T Yokota; F Lee; D Rennick; C Hall; N Arai; T Mosmann; G Nabel; H Cantor; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  Purification and physicochemical characterization of murine T cell replacing factor (TRF).

Authors:  K Takatsu; N Harada; Y Hara; Y Takahama; G Yamada; K Dobashi; T Hamaoka
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

6.  BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).

Authors:  N Harada; Y Kikuchi; A Tominaga; S Takaki; K Takatsu
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

7.  Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.

Authors:  K Takatsu; K Tanaka; A Tominaga; Y Kumahara; T Hamaoka
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

8.  Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor.

Authors:  S Nagata; M Tsuchiya; S Asano; Y Kaziro; T Yamazaki; O Yamamoto; Y Hirata; N Kubota; M Oheda; H Nomura
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum.

Authors:  J F DeLamarter; J J Mermod; C M Liang; J F Eliason; D R Thatcher
Journal:  EMBO J       Date:  1985-10       Impact factor: 11.598

View more
  133 in total

1.  C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses.

Authors:  T Morokata; J Ishikawa; K Ida; T Yamada
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Clonal expansion of T cells infiltrating in the airways of non-atopic asthmatics.

Authors:  T Umibe; Y Kita; A Nakao; H Nakajima; T Fukuda; S Yoshida; T Sakamaki; Y Saito; I Iwamoto
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

4.  Mitochondria in eosinophils: functional role in apoptosis but not respiration.

Authors:  K K Peachman; D S Lyles; D A Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 5.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

6.  Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.

Authors:  A Iwama; J Pan; P Zhang; W Reith; B Mach; D G Tenen; Z Sun
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

7.  Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats.

Authors:  A Haczku; P Macary; T J Huang; H Tsukagoshi; P J Barnes; A B Kay; D M Kemeny; K F Chung; R Moqbel
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 8.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

9.  Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.

Authors:  H Endo; I Iwamoto; M Fujita; S Okamoto; S Yoshida
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 10.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.